Discover how Aβ−3–40, a novel cerebrospinal fluid biomarker, is revolutionizing early Alzheimer's disease detection through advanced biochemical analysis.
Exploring how cerebrospinal fluid stagnation and optic nerve compartmentation contribute to toxicity in normal-tension glaucoma.